J Int.Soc.Sports Nutr
We have treated dozens of patients and are receiving excellent feedback about the program and weight loss results
In a study comparing the two drugs for weight loss, people lost an average of 5.9% of their body weight in three months with Tirzepatide, compared to 3.6% with Semaglutide [1]
Most common adverse reactions for Wegovy (semaglutide) The most common adverse reactions for Wegovy (incidence 5%) are nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss